phentolamine has been researched along with Neurally Mediated Faint in 1 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Saito, F | 1 |
Imai, S | 1 |
Tanaka, N | 1 |
Tanaka, H | 1 |
Suzuki, K | 1 |
Takase, H | 1 |
Aoyama, H | 1 |
Matsudaira, K | 1 |
Ebuchi, T | 1 |
Akamine, Y | 1 |
Takahashi, N | 1 |
Sugino, K | 1 |
Kanmatsuse, K | 1 |
Yagi, H | 1 |
Kushiro, T | 1 |
1 other study available for phentolamine and Neurally Mediated Faint
Article | Year |
---|---|
Basic autonomic nervous function in patients with neurocardiogenic syncope.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adren | 2007 |